We have been receiving a lot of enquiries from patients who are worried that they have received the Astra Zeneca vaccine which some European countries are claiming has not been safety tested to the same standard as that manufactured in Europe.
This is the information that I have received from the National Vaccination Programme Team and the Government.
The following information has been provided by the National Vaccination Programme Team and the Government in response to similar enquiries.
National vaccination programme:
“We can confirm that the AstraZeneca vaccine manufactured in India is exactly the same as the batches manufactured in Europe. There is no difference in efficacy or safety. As with other medicines, the MHRA ensures that all manufacturers of vaccines, as well as all batches produced, meet the same high standards of quality, safety and efficacy before they can be used in the U.K.
The issues reported in the media relate to international travel only and not to the safety or efficacy of the vaccine. The government is leading on mechanisms which will support international travel. Vaccination teams are advised to counsel and reassure patients who express a concern or have questions on this subject.”
“The Government has confirmed that no Covishield vaccines have been administered in the UK and that all AstraZeneca vaccines given in the UK appear on the NHS COVID Pass as Vaxzevria. The NHS COVID Pass is the digital version of individuals’ proof of COVID-19 vaccine status, which has been available for international travel since May. The European Medicines Agency has authorised this vaccine and the Government is confident that travel will not be affected. The EU Digital Covid-19 Certificate is currently for EU citizens only, or third country nationals legally staying or resident in the EU.”
We do understand why patients are worried but unfortunately there really isn’t anything that we can do to help the situation.
Balmore Park Surgery